AstroNova Q4 revenue $39.9M (+34% YoY); EPS $0.18; backlog $35.8M

AstroNova, Inc.

2023-FY EPS reported $0.36 revenue$142,527,000

Q4 revenue $39.9M (+34% YoY); net income $1.4M vs. loss of $0.8M a year ago.
Q4 diluted EPS $0.18; adjusted EBITDA $3.9M (9.7% of revenue).
Full-year revenue $142.5M, net income $2.7M ($0.36 diluted EPS).
Product ID rev $28.1M (+26% YoY) from Astro Machine acquisition; Test & Measurement rev $11.7M (+61% YoY).
Q4 bookings $36.6M; year-end backlog $35.8M, up from $27.8M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AstroNova, Inc. reported full year ended January 31, 2023 results: revenue $142.5 million, net income $2.7 million, EPS $0.36 per diluted share.

Period: full year ended January 31, 2023
Revenue: $142.5 million
Net income: $2.7 million
EPS: $0.36 per diluted share
Result: reported results

Exact text from the filing

Revenue of $142.5 million Operating income of $5.4 million Net income of $2.7 million, or $0.36 per diluted share

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AstroNova, Inc. reported fourth quarter ended January 31, 2023 results: revenue $39.9 million, net income $1.4 million, EPS $0.18 per diluted share.

Period: fourth quarter ended January 31, 2023
Revenue: $39.9 million
Net income: $1.4 million
EPS: $0.18 per diluted share
Result: reported results

Exact text from the filing

Revenue of $39.9 million Operating income of $2.1 million Net income of $1.4 million, or $0.18 per diluted share

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

AstroNova, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-23-000479

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.